BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30842274)

  • 21. Human hepatitis B virus surface and e antigens inhibit major vault protein signaling in interferon induction pathways.
    Liu S; Peng N; Xie J; Hao Q; Zhang M; Zhang Y; Xia Z; Xu G; Zhao F; Wang Q; Han T; Zhu Y
    J Hepatol; 2015 May; 62(5):1015-23. PubMed ID: 25481566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-10 plays a central regulatory role in the cytokines induced by hepatitis C virus core protein and polyinosinic acid:polycytodylic acid.
    Pang X; Wang Z; Zhai N; Zhang Q; Song H; Zhang Y; Li T; Li H; Su L; Niu J; Tu Z
    Int Immunopharmacol; 2016 Sep; 38():284-90. PubMed ID: 27337528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B Virus Particles Activate Toll-Like Receptor 2 Signaling Initially Upon Infection of Primary Human Hepatocytes.
    Zhang Z; Trippler M; Real CI; Werner M; Luo X; Schefczyk S; Kemper T; Anastasiou OE; Ladiges Y; Treckmann J; Paul A; Baba HA; Allweiss L; Dandri M; Gerken G; Wedemeyer H; Schlaak JF; Lu M; Broering R
    Hepatology; 2020 Sep; 72(3):829-844. PubMed ID: 31925967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid-induced S-adenosylmethionine enhances the interferon signaling pathway by restoring STAT1 protein methylation in hepatitis B virus-infected cells.
    Bing Y; Zhu S; Yu G; Li T; Liu W; Li C; Wang Y; Qi H; Guo T; Yuan Y; He Y; Liu Z; Liu Q
    J Biol Chem; 2014 Nov; 289(47):32639-55. PubMed ID: 25271158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
    Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
    Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific engagement of TLR4 or TLR3 does not lead to IFN-beta-mediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophages.
    Punturieri A; Alviani RS; Polak T; Copper P; Sonstein J; Curtis JL
    J Immunol; 2004 Jul; 173(2):1033-42. PubMed ID: 15240691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
    Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
    J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essential involvement of cross-talk between IFN-gamma and TNF-alpha in CXCL10 production in human THP-1 monocytes.
    Qi XF; Kim DH; Yoon YS; Jin D; Huang XZ; Li JH; Deung YK; Lee KJ
    J Cell Physiol; 2009 Sep; 220(3):690-7. PubMed ID: 19472212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR3 Activation of Hepatic Stellate Cell Line Suppresses HBV Replication in HepG2 Cells.
    Zhang B; Liu Y; Wang X; Li J; Xu X; Guo L; Ho WZ
    Front Immunol; 2018; 9():2921. PubMed ID: 30619284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of hepatitis B virus replication by MyD88 is mediated by nuclear factor-kappaB activation.
    Lin S; Wu M; Xu Y; Xiong W; Yi Z; Zhang X; Zhenghong Y
    Biochim Biophys Acta; 2007 Oct; 1772(10):1150-7. PubMed ID: 17935950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of STAT1 methylation is involved in the resistance of hepatitis B virus to Interferon alpha.
    Li J; Chen F; Zheng M; Zhu H; Zhao D; Liu W; Liu W; Chen Z
    Antiviral Res; 2010 Mar; 85(3):463-9. PubMed ID: 19857525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
    Zhang E; Lu M
    Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent manner.
    Strassheim D; Riddle SR; Burke DL; Geraci MW; Stenmark KR
    J Immunol; 2009 Dec; 183(11):6981-8. PubMed ID: 19915063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOCS1-negative feedback of STAT1 activation is a key pathway in the dsRNA-induced innate immune response of human keratinocytes.
    Dai X; Sayama K; Yamasaki K; Tohyama M; Shirakata Y; Hanakawa Y; Tokumaru S; Yahata Y; Yang L; Yoshimura A; Hashimoto K
    J Invest Dermatol; 2006 Jul; 126(7):1574-81. PubMed ID: 16628196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trapidil inhibits monocyte CD40 expression by preventing IFN-gamma-induced STAT1 S727 phosphorylation.
    Zhou L; Schandené L; Mordvinov VA; Chatelain P; Pradier O; Goldman M; Stordeur P
    Int Immunopharmacol; 2004 Jul; 4(7):863-71. PubMed ID: 15182726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The production of IL-1 receptor antagonist in IFN-beta-stimulated human monocytes depends on the activation of phosphatidylinositol 3-kinase but not of STAT1.
    Molnarfi N; Hyka-Nouspikel N; Gruaz L; Dayer JM; Burger D
    J Immunol; 2005 Mar; 174(5):2974-80. PubMed ID: 15728510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells.
    Yen JH; Kong W; Hooper KM; Emig F; Rahbari KM; Kuo PC; Scofield BA; Ganea D
    J Leukoc Biol; 2015 Nov; 98(5):689-702. PubMed ID: 26059829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of interferon-α signaling by hepatitis E virus.
    Dong C; Zafrullah M; Mixson-Hayden T; Dai X; Liang J; Meng J; Kamili S
    Hepatology; 2012 May; 55(5):1324-32. PubMed ID: 22183878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-CSP inhibiting hepatitis B virus in HepG2.2.15 cells involves JAK-STAT signal pathway.
    Lu X; Wang J; Jin X; Huang Y; Zeng W; Zhu J
    Biomed Res Int; 2015; 2015():959684. PubMed ID: 25861653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.